PORTFOLIO COMPANY

Souvien Therapeutics

souvien therapeutics

Dementia and neurodegenerative conditions are a tremendous burden on our healthcare system and economy.

Souvien Therapeutics is a biotechnology company focused on developing novel therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.

The drug discovery strategy is based on a substantial body of data implicating a critical epigenetic regulator of cellular aging in neurodegeneration. The goal is to use that knowledge, and the greatly evolving understanding of aging, to bring new medicines into human trials.